< Go Back

Pharnext Announces Pleotherapy Proof of Concept in Charcot-Marie-Tooth Disease Type 1A through Two Peer-Reviewed Publications Spanish
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend
Oasis Health Products, Inc. Announces Completion Of Stability Testing On Itonis, Inc.'s EMESYL™ Nausea Relief
Kenneth O. Klepper appointed to Diplomat Board of Directors
MEI Pharma Completes Public Offering of Common Stock
Iodine Launches Cold and Flu App That Helps Smart Consumers Find the Best Over-The-Counter Options For Their Symptoms
Chronic Urticaria / Hives Therapeutic Pipeline H2 2014 Review Research Report
Global Excipients Market 2014-2018: Key Vendors are BASF, Colorcon, FMC, Fuji Chemicals Industry and The Dow Chemical
Aptuit Adds Hot Melt Extrusion Technology To Its Integrated API And Formulation Development Expertise
New Technologies that will Impact the Global Pharmaceutical Packaging Industry
First Patient Treated in Mapi Pharma's Phase IIa Clinical Trial of GA Depot for Relapsing Remitting Multiple Sclerosis (RRMS)
PAREXEL International Announces Date Of Second Quarter Fiscal Year 2015 Earnings Release And Conference Call
BOTTINI & BOTTINI, INC. Files Class Action Lawsuit On Behalf Of Persons Who Sold Allergan Stock Between February 25, 2014 And April 21, 2014
Kinex Pharmaceuticals Appoints Chief Operating Officer
Mylan to Present at the J.P. Morgan 33rd Annual Healthcare Conference
Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology
Generex Announces Participation in MedCannAccess® - CannScience Partnership on Non-Smoked Forms of Marijuana
Physicians Interactive Chairman and CEO Donato Tramuto Honored with Robert F. Kennedy Ripple of Hope Award
Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications
Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture
VASCAZEN® POMEGA Phase IIa trial protocol cleared clinical evaluation by French FDA
RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301
IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019
ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine
Dompé Offers a New "Window" on the World of Scientific Research, with the Website, Dedicated to Clinical Trials
Cardio3 Biosciences Will be Present at ODDO Midcap Forum
Xarelto Cases Centralized in Louisiana - Meyerkord & Meyerkord, LLC Accepting Cases Nationwide
Veloxis announces that it has filed an action against the Food and Drug Administration, seeking an order requiring FDA to grant final approval to Envarsus® XR
NCPA: Medicare Study Demands More Pharmacy Competition, Choice
Aratana Therapeutics Initiates Pivotal Study for AT-003
Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board
Alexza Amends Autoliv Agreement for Heat Packages Used in ADASUVE®
PCMA: Is CMS' Study on Medicare Part D Preferred Pharmacies a Pretext for Major Changes?
Lilly's CYRAMZA® (ramucirumab) Receives Third FDA Approval
TPI Expects Receiving GMP by the end of December 2014
The Global Pharmacy Information System Market is Estimated to Grow at a CAGR of 7.7% From 2013 to 2019
Plasma Fractionation Market Worth $25,383.4 Million by 2019
Former Executive At IBM, Cisco Systems, Hewlett-Packard, BearingPoint And KPMG Joins Maetrics Spanish
HedgePath Pharmaceuticals Receives IND Clearance to Commence Development of its Proposed Cancer Treatment
From Fish Food to Superfood: Marine Phytoplankton 5000 Gives Consumers Powerful Defense Against Ravages of Oxidative Stress
NewGen Therapeutics Targeted Anti-Cancer Drug, NT-113, Demonstrates Compelling Activity in Glioblastoma Xenograft Models
RD Legal Funding Can Accelerate Delayed Settled Case Fees to Plaintiffs' Attorneys with Pharmaceutical Cases
BHI Celebrates Funding Successes of Clients BeneVir BioPharm, Inc. and Perceptive Navigation, LLC
Lightlake Therapeutics Inc. Announces Licensing Deal With Adapt Pharma Limited Subsidiary
Alimera Sciences Added to NASDAQ Biotechnology Index
SOV Therapeutics announces Successful Phase IIb Study of Oral Testosterone Undecanoate for Treatment of Primary and Secondary Hypogonadism in Adult Males
Yew Bio-Pharm to Enter U.S. Health Supplement Market With Two New Agaric Polysaccharide Products Focused on Enhancing Immunity
Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder
DURECT Enters into License Agreement Granting Santen the Worldwide Rights to a Sustained Release SABER® Ophthalmology Product
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition

< Prev Next >
PR Newswire - United Business Media